Skip to main content
| News

Economic promotion agency creates 55 new jobs in Jura

10.06.2022

The economic promotion agency of the canton of Jura supported a total of 26 companies in founding, establishing a presence and developing in 2021. These companies ultimately invested a sum of 44.1 million Swiss francs. In addition to the 55 newly created positions, 181 are set to be added over the medium term.

The site Jura of the Switzerland Innovation Park Basel Area (img: Biondopictures)

The economic promotion agency of the canton of Jura can look back with satisfaction at a successful 2021. The 26 companies supported by the agency invested 44.1 million Swiss francs in the region. Over the medium term, a further 181 new jobs are to be added to the 55 created in 2021, which represents an increase on previous years. For example, in 2020 a total of 33 companies invested a sum of 9.4 million Swiss francs with 36 new jobs created, which should lead to an overall total of 107 in time.

According to the annual report published by the cantonal economic promotion agency, eight of the 26 companies in 2021 were newly founded. These created 22 jobs, with a further 55 set to follow in due course. In total, 15 existing companies implemented expansion plans with the support of the economic promotion agency, leading to the creation of 18 new jobs, with a further 81 to follow eventually. At 36.0 million Swiss francs, they accounted for the largest share of investments. Three companies were relocated in cooperation with the regional investment and innovation promotion agency Basel Area Business & Innovation. These firms invested a total of 1.6 million Swiss francs and created 15 jobs, with 45 more to follow.

Settlement of French medtech firm Biosynex

The Switzerland Innovation Park Basel Area also forms part of the regional innovation ecosystem. Overall, 13 companies with a total of 25 employees are now operating from its branch in Courroux, which was first opened in 2019.

The press conference was held at Biosynex Suisse SA. The Swiss subsidiary of the French medtech firm established a presence in the region in 2021 with the help of the Basel Area Business & Innovation.

According to Jacques Gerber, Head of the Directorate for Economic Affairs of the canton of Jura, the Jura economy has now put the crisis to bed. Nevertheless, some challenges remain, he explains in the annual report. For this reason, in the near future the cantonal government will be presenting a program for economic development over the next five years.

(Read more about starting a business in Switzerland)

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

KUORI developing biodegradable plastics
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Sustainability

KUORI developing biodegradable plastics

The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...

Read More
Cell and gene therapies gain momentum in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...

Read More
BLKB expanding support for startups
Basel Area Business & Innovation, Innovation, Invest

BLKB expanding support for startups

BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...

Read More
Combatting the rise of antimicrobial resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Combatting the rise of antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...

Read More
AMR Action Fund invests in new antibiotics developed by BioVersys
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

AMR Action Fund invests in new antibiotics developed by BioVersys

The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...

Read More
Investors give Resistell 8.5 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Investors give Resistell 8.5 million Swiss francs

Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...

Read More
1 2 3 31

Do you have a question? We'd like to hear from you.